I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Smith, John Richard, SHAI / HATI3
Hōputu: Recurso digital
Reo:Ingarihi
I whakaputaina: Zenodo 2026
Ngā marau:
Urunga tuihono:https://doi.org/10.5281/zenodo.19737247
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
_version_ 1866901234820055040
author Smith, John Richard
SHAI / HATI3
author_facet Smith, John Richard
SHAI / HATI3
contents <h2><span>Abstract</span></h2> <p><span>We report the results of a pre-registered confirmatory analysis (OSF osf.io/C6u3t) that failed. The hypothesis — that mesoscale spatial autocorrelation (ρ_meso) would be consistently higher in tumour tissue than matched normal tissue across four signalling channels in NSCLC — was not confirmed at the pre-registered significance threshold across the full 7-patient cohort from E-MTAB-13530.</span></p> <p> </p> <p><span>The pre-registered verdict is </span><span>failure to replicate</span><span> (0/4 channels reaching Bonferroni-corrected significance for ρ_meso; 4/7 patients showing ≥3/4 channels with tumour > normal).</span></p> <p> </p> <p><span>However, the data reveal three findings that survive the failed hypothesis. First, the proliferation channel shows unanimously higher spatial autocorrelation in tumour tissue (7/7 patients, Global Moran's I p=0.0078 — reaching Bonferroni-corrected significance in this cohort, subject to the UMI depth limitation noted below), suggesting that proliferative fronts create detectable mesoscale gradients absent in normal lung. Second, the four signalling channels behave differently in biologically interpretable ways: immune and proliferation channels consistently show tumour > normal, while EMT and hypoxia do not. Third, the two patients (P17, P24) who deviate most strongly from the majority pattern are clinically distinct — P17 is the only histologically unclassifiable (NSCLC-NOS) patient with the smallest tumour, and P24 is the youngest patient in the cohort. These observations generate testable hypotheses about the relationship between histological subtype, tumour size, molecular driver, and spatial organisation, but they do not confirm any framework prediction. The outlier analysis is post-hoc and hypothesis-generating, not confirmatory.</span></p> <p> </p> <p><span>The scale mismatch finding from SIP-ONC-01A is replicated: standard-resolution spatial transcriptomics (Visium, 55 μm) measures pathophysiological organisation, not developmental coordination, across the full cohort.</span></p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_19737247
institution Zenodo
language eng
publishDate 2026
publisher Zenodo
record_format zenodo
spellingShingle SIP-ONC-01B: A Pre-Registered Hypothesis That Failed — What Mesoscale Spatial Autocorrelation Reveals About NSCLC Heterogeneity
Smith, John Richard
SHAI / HATI3
spatial transcriptomics, spatial autocorrelation, non-small cell lung cancer, NSCLC, pre-registered replication failure, tumour microenvironment, variogram analysis, Global Moran's I, mesoscale spatial organisation, proliferative front, scale mismatch, Visium, pathophysiological gradients, developmental coordination, channel-specific biology, negative result, open science
<h2><span>Abstract</span></h2> <p><span>We report the results of a pre-registered confirmatory analysis (OSF osf.io/C6u3t) that failed. The hypothesis — that mesoscale spatial autocorrelation (ρ_meso) would be consistently higher in tumour tissue than matched normal tissue across four signalling channels in NSCLC — was not confirmed at the pre-registered significance threshold across the full 7-patient cohort from E-MTAB-13530.</span></p> <p> </p> <p><span>The pre-registered verdict is </span><span>failure to replicate</span><span> (0/4 channels reaching Bonferroni-corrected significance for ρ_meso; 4/7 patients showing ≥3/4 channels with tumour > normal).</span></p> <p> </p> <p><span>However, the data reveal three findings that survive the failed hypothesis. First, the proliferation channel shows unanimously higher spatial autocorrelation in tumour tissue (7/7 patients, Global Moran's I p=0.0078 — reaching Bonferroni-corrected significance in this cohort, subject to the UMI depth limitation noted below), suggesting that proliferative fronts create detectable mesoscale gradients absent in normal lung. Second, the four signalling channels behave differently in biologically interpretable ways: immune and proliferation channels consistently show tumour > normal, while EMT and hypoxia do not. Third, the two patients (P17, P24) who deviate most strongly from the majority pattern are clinically distinct — P17 is the only histologically unclassifiable (NSCLC-NOS) patient with the smallest tumour, and P24 is the youngest patient in the cohort. These observations generate testable hypotheses about the relationship between histological subtype, tumour size, molecular driver, and spatial organisation, but they do not confirm any framework prediction. The outlier analysis is post-hoc and hypothesis-generating, not confirmatory.</span></p> <p> </p> <p><span>The scale mismatch finding from SIP-ONC-01A is replicated: standard-resolution spatial transcriptomics (Visium, 55 μm) measures pathophysiological organisation, not developmental coordination, across the full cohort.</span></p>
title SIP-ONC-01B: A Pre-Registered Hypothesis That Failed — What Mesoscale Spatial Autocorrelation Reveals About NSCLC Heterogeneity
topic spatial transcriptomics, spatial autocorrelation, non-small cell lung cancer, NSCLC, pre-registered replication failure, tumour microenvironment, variogram analysis, Global Moran's I, mesoscale spatial organisation, proliferative front, scale mismatch, Visium, pathophysiological gradients, developmental coordination, channel-specific biology, negative result, open science
url https://doi.org/10.5281/zenodo.19737247